GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Helius Medical
Helius Medical is developing a neurostimulation device for the rehabilitation of patients with traumatic brain injuries. Its stock price reflects the struggle to commercialize and gain widespread acceptance of this innovative technology.
Share prices of companies in the market segment - Neuro
Helius Medical Technologies is a neurotechnology company that has developed a portable tongue stimulator to improve balance and gait in patients with multiple sclerosis. We've categorized it under the "Neurology" category. The chart below shows how the market is performing for non-invasive neurostimulation methods.
Broad Market Index - GURU.Markets
Helius Medical is a neurotechnology company that has developed the non-invasive PoNS device for nerve stimulation to help rehabilitate patients with neurological symptoms. It is a component of the GURU.Markets index, and the chart below shows how its stock compares to the market.
Change in the price of a company, segment, and market as a whole per day
HSDT - Daily change in the company's share price Helius Medical
Helius Medical Technologies' daily share price fluctuations reflect the high volatility inherent in biotech companies. This metric measures the company's sensitivity to news about clinical trials of its neurostimulation device.
Daily change in the price of a set of shares in a market segment - Neuro
Helius Medical Technologies, Inc. is a medical technology company. This chart illustrates the high volatility of the MedTech industry. Comparing it to HSDT, which focuses on neurostimulation, helps assess the extent to which its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
Helius Medical develops non-invasive technologies for the treatment of neurological diseases. This innovative medtech company's shares are responding to clinical successes and regulatory decisions. Its history reflects the medtech sector's contribution to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Helius Medical
For Helius Medical Technologies, the year-over-year trend is a story about the commercialization of its neurostimulation device. Its market capitalization growth over the past 12 months reflects its success in promoting its PoNS device, which is used to rehabilitate patients with traumatic brain injuries and multiple sclerosis by stimulating neuroplasticity.
Annual dynamics of market capitalization of the market segment - Neuro
Helius, a company developing therapies for recovery from neurological injuries, is betting on medical innovation. Its performance relative to the sector will reveal how much investors believe in its ability to commercialize its unique technology and secure insurance coverage.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Helius is a very small and highly speculative medical technology company. Its stock price has nothing to do with fundamentals or the economy, but is driven by news of trials and investor confidence in the potential of its developments, making it a high-risk bet.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Helius Medical
Helius Medical is a neurotechnology company commercializing the PoNS rehabilitation device. Its monthly performance reflects progress in securing insurance approvals and sales growth. News of new clinical data also plays a significant role.
Monthly dynamics of market capitalization of the market segment - Neuro
This chart illustrates the dynamics of the neurotechnology sector. For Helius, which is commercializing the PoNS device, it provides context. Its movements reflect progress in securing insurance approvals and sales growth, which are key for the entire neurostimulation niche.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Helius Medical develops and commercializes a non-invasive neurostimulation device designed to rehabilitate patients with neurological injuries. A full-market chart allows you to assess how Helius's stock, as a medical technology company, is influenced by its own news, rather than by overall market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Helius Medical
Helius Medical, which develops a portable device for neurostimulation and rehabilitation for patients with traumatic brain injuries, is extremely sensitive to news. Weekly stock price movements reflect the publication of clinical data, regulatory approvals, and partnerships with rehabilitation centers.
Weekly dynamics of market capitalization of the market segment - Neuro
Helius Medical operates in the medical technology sector, where broad technological breakthroughs and regulatory decisions impact everyone. The success of one company can boost the entire segment. The chart will show whether HSDT is perceived by the market as a promising player or simply part of the broader neurotechnology landscape.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Helius Medical, as a biotech company, often ignores broader market trends. Its fate depends not on GDP or inflation, but on FDA decisions and commercialization success. The chart below clearly demonstrates how HSDT shares can live their own life, separate from the broader market.
Market capitalization of the company, segment and market as a whole
HSDT - Market capitalization of the company Helius Medical
Helius Medical's market capitalization is a story about treating the effects of traumatic brain injury. The stock price of this company, which is developing a non-invasive nerve stimulation device, reflects investor hopes for its technology. Its volatile performance reflects the market's assessment of its clinical data and the long road to widespread acceptance.
HSDT - Share of the company's market capitalization Helius Medical within the market segment - Neuro
Helius Medical Technologies develops a non-invasive neurostimulation device that aids in the rehabilitation of patients with traumatic brain injuries. Its share of the neurological equipment sector is based on this unique technology. The chart shows the relevance of its approach for restoring brain function.
Market capitalization of the market segment - Neuro
Helius Medical Technologies develops non-invasive brain stimulation technologies for the rehabilitation of patients with neurological injuries. The chart below shows the market capitalization of the neurological sector. This represents a market seeking new ways to restore brain function.
Market capitalization of all companies included in a broad market index - GURU.Markets
Helius Medical developed a portable PoNS device for non-invasive cranial nerve stimulation for rehabilitation after traumatic brain injury and stroke. Its market capitalization is a bet on this technology. The chart below shows the share price of companies working in the field of neurorehabilitation.
Book value capitalization of the company, segment and market as a whole
HSDT - Book value capitalization of the company Helius Medical
Helius Medical is based on a unique medical device. The company's book value reflects its patents and inventory of the portable tongue stimulator (PoNS), which is used to rehabilitate patients with traumatic brain injuries and multiple sclerosis. The chart below shows how the company is building the material base for commercializing its technology.
HSDT - Share of the company's book capitalization Helius Medical within the market segment - Neuro
Helius Medical develops neurostimulation devices, relying on R&D centers and partner manufacturing facilities. The S_BCap_Seg graph shows its share of the physical infrastructure of the innovative neurotechnology sector.
Market segment balance sheet capitalization - Neuro
Helius Medical develops neurostimulation devices. The medical technology business requires investment in both R&D to obtain approvals and manufacturing capacity. The chart shows the balance between its intangible assets (patents) and tangible assets (equipment).
Book value of all companies included in the broad market index - GURU.Markets
Helius Medical's assets are focused on nervous system restoration technology. The company's book value reflects its manufacturing capacity for the PoNS device, which stimulates language to improve brain function. This technology is designed to help stroke and multiple sclerosis patients.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Helius Medical
Helius Medical is developing the PoNS neurostimulation device, which aids in rehabilitation after traumatic brain injuries. The company's book value is modest. Its market capitalization is based on its unique technology, patents, and potential to help patients regain lost function.
Market to book capitalization ratio in a market segment - Neuro
Helius Medical develops and markets neurostimulation devices. Its value lies in its unique technology and clinical data. The chart shows the market premium for its innovative approach to patient rehabilitation compared to its tangible assets.
Market to book capitalization ratio for the market as a whole
Helius Medical develops and markets neurostimulation devices for the treatment of neurological symptoms. The company's value lies in its unique technology and potential to help patients with traumatic brain injuries. The chart shows the premium investors place on innovative medical technologies, valuing the company above its tangible assets.
Debts of the company, segment and market as a whole
HSDT - Company debts Helius Medical
Helius Medical, a company developing therapies for neurological patients, is using debt for commercialization and further research. This chart shows how the company is funding the marketing of its nerve stimulation device and new clinical trials to expand its use in various conditions.
Market segment debts - Neuro
Helius Medical is developing a portable neurostimulation device for the rehabilitation of patients with neurological injuries. While in the commercialization phase of its product, it incurs significant marketing and sales expenses. This chart shows how the company is managing its financial resources on its path to profitability.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Helius Medical
Helius Medical is a neurotechnology company developing devices to treat neurological symptoms. This chart shows the extent to which its survival and growth depend on debt. For a company with an innovative but not yet widely available product, debt is an indicator of faith in the technology, which comes with high risk.
Market segment debt to market segment book capitalization - Neuro
Helius Medical develops technologies to treat neurological symptoms. This business requires significant investment in R&D and clinical trials. This chart for the neurotechnology sector shows how the industry as a whole funds its innovations, allowing one to assess the company's aggressive strategy in this cutting-edge market.
Debt to book value of all companies in the market
Helius Medical is a neurotechnology company developing devices for the rehabilitation of patients with neurological injuries and diseases. This chart, which reflects the overall debt-to-book value ratio of the market, is important for understanding the investment climate. Availability of capital is critical for funding clinical trials and bringing new medical technologies to market.
P/E of the company, segment and market as a whole
P/E - Helius Medical
Helius Medical develops and markets the PoNS (Portable Neuromodulation Stimulator), a device used to rehabilitate patients with neurological symptoms. This chart reflects their belief in innovative treatment methods. Its dynamics show how investors assess the potential for this technology to be implemented in clinical practice to help patients after injuries and strokes.
P/E of the market segment - Neuro
Helius Medical represents the medical device sector. This chart shows the average price-to-earnings ratio (P/E) for this innovative industry. Comparing the company's P/E to this ratio allows one to assess how highly the market values its PoNS neuromodulation technology and its commercial potential compared to other medical devices on the market.
P/E of the market as a whole
Helius Medical develops and markets the PoNS device, which is used for neurostimulation in rehabilitation after traumatic brain injury and stroke. The company's success depends on the widespread adoption of its technology. This chart reflects sentiment in the medical device sector. It helps understand whether the market sees Helius' potential to change the standards of neurorehabilitation and how it assesses its commercial prospects.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Helius Medical
Helius Medical Technologies develops and markets a neurostimulation device designed to improve function in patients with neurological injuries. The graph shows future revenue expectations, which depend on physician and patient acceptance of the technology, as well as insurance coverage for the procedures.
%20P%2FE%20Helius%20Medical&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Helius-Medical&v=1772566145330 "Chart of the company's future (projected) P/E Helius Medical")
Future (projected) P/E of the market segment - Neuro
Helius Medical Technologies has developed a portable tongue neurostimulation device designed to complement gait-improving therapy for patients with multiple sclerosis. This graph shows how its future revenue expectations compare to the industry average, reflecting its innovative approach to rehabilitation.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Neuro&v=1772566145437 "Future (projected) P/E graph of the market segment - Neuro")
Future (projected) P/E of the market as a whole
Helius Medical Technologies develops and markets neurostimulation devices designed to rehabilitate patients with traumatic brain injuries. The company's success depends on the implementation of its technology in clinical practice. This is a story of medical innovation unrelated to general economic cycles.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772566145476 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Helius Medical
Helius Medical Technologies develops and markets the non-invasive PoNS neurostimulation device, intended for use as a complementary therapy for neurological symptoms. The company's revenue depends on the clinical adoption of this technology. This chart shows the company's financial progress toward commercializing this innovative medical device.
Profit of companies in the market segment - Neuro
Helius Medical Technologies develops and markets the PoNS device, designed for non-invasive cranial nerve stimulation to improve symptoms in patients with multiple sclerosis and traumatic brain injury. This graph shows the profitability of the neurology segment. The commercial success of this breakthrough technology directly impacts the development and profitability of this entire innovative niche.
Overall market profit
Helius Medical Technologies develops and markets neurostimulation devices designed to rehabilitate patients with neurological injuries. The adoption of such innovative technologies in medical practice is a long-term process, largely unaffected by short-term economic cycles. This chart illustrates the overall market dynamics against which Helius is charting its path.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Helius Medical
Helius Medical Technologies develops and markets the PoNS neurostimulation device, designed to rehabilitate patients with traumatic brain injuries and multiple sclerosis. This graph reflects analysts' future revenue expectations, which depend on the adoption of this technology by rehabilitation centers and the receipt of insurance coverage for patients.
%20profit%20of%20the%20company%20Helius%20Medical&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Helius-Medical&v=1772566145842 "Graph of future (projected) profit of the company Helius Medical")
Future (predicted) profit of companies in the market segment - Neuro
Helius Medical Technologies develops and commercializes technologies aimed at neurostimulation and neurological restoration. This chart shows profitability forecasts for the neurological sector. It reflects expectations for innovative treatments for the effects of brain injury and disease.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Neuro&v=1772566145914 "Graph of future (predicted) profits of companies in a market segment - Neuro")
Future (predicted) profit of the market as a whole
Helius Medical develops technologies for the treatment of neurological symptoms. The introduction of new medical devices requires investment from the healthcare system. The overall profit forecast, shown in the graph, reflects the economic ability of the government and hospitals to finance innovation, which directly impacts Helius's market potential.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772566145991 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Helius Medical
Helius Medical is a neurotechnology company that has developed a device for the treatment of neurological symptoms. At the commercialization stage, the P/S ratio is a key metric. It reflects how investors assess the acceptance of the company's innovative product by the medical community and its potential for sales growth.
P/S market segment - Neuro
Helius Medical Technologies develops and markets a non-invasive neurostimulation device designed to improve function in patients with neurological conditions, such as traumatic brain injury. This chart shows how the market perceives the potential of their unique technology and its commercial prospects in neurorehabilitation.
P/S of the market as a whole
Helius Medical develops and markets neurostimulation devices designed to rehabilitate patients with neurological injuries. Revenue depends on the adoption of its technology in clinical practice. This chart illustrates the average revenue estimate, which helps understand the market premium for revenue from innovative rehabilitation technologies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Helius Medical
Helius Medical develops and markets a portable neurostimulation device intended for use as a complementary therapy for neurological diseases, such as multiple sclerosis. This chart reflects investor expectations for future sales of this innovative device, which are contingent on its acceptance by the medical community.
%20P%2FS%20Helius%20Medical&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Helius-Medical&v=1772566146183 "The graph of the company's future (projected) P/S Helius Medical")
Future (projected) P/S of the market segment - Neuro
Helius Medical Technologies, Inc. is a neurotechnology company focused on treating neurological symptoms caused by disease or injury using its PoNS device. This chart shows how the market estimates the future sales of its innovative technology. It compares it to other companies in the neuroscience sector, reflecting its potential for patient rehabilitation.
%20P%2FS%20market%20segment%20graph%20-%20Neuro&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Neuro&v=1772566146234 "Future (projected) P/S market segment graph - Neuro")
Future (projected) P/S of the market as a whole
Helius Medical develops and markets a neurostimulation device designed to rehabilitate patients with traumatic brain injuries. The company operates at the intersection of medicine and technology. This chart shows aggregate market expectations for future revenue, and HSDT demonstrates how innovative medical devices can open up new treatment opportunities.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772566146261 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Helius Medical
Helius Medical Technologies is a neurotechnology company focused on neurological health. Its revenue, shown in this chart, is generated by sales of the innovative non-invasive PoNS device, which is used for nerve stimulation and is intended for the rehabilitation of patients with neurological symptoms.
Sales of companies in the market segment - Neuro
Helius Medical Technologies develops and markets neurostimulation devices. This chart shows revenue from sales of its flagship product, PoNS. It allows investors to track commercialization progress and assess the success of its innovative technology in the rehabilitation market.
Overall market sales
Helius Medical Technologies develops neurostimulation devices. The need for treatment of neurological conditions is not dependent on economics. This schedule is not a significant factor for Helius. Its success is determined by clinical data, regulatory approval, and the ability to convince doctors and patients of the effectiveness of its technology.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Helius Medical
Helius Medical Technologies develops and markets non-invasive neurostimulation devices to improve function in patients with neurological diseases. Its revenue forecast depends on the adoption of its technology in rehabilitation practices. This chart shows analysts' expectations for the commercialization of its innovative approach.
%20sales%20of%20the%20company%20Helius%20Medical&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Helius-Medical&v=1772566146537 "Schedule of future (projected) sales of the company Helius Medical")
Future (projected) sales of companies in the market segment - Neuro
Helius Medical Technologies develops and markets neurostimulation devices designed to rehabilitate patients with neurological disorders. This graph shows projected revenue for the entire neurological segment. It helps estimate the potential demand for innovative treatments, which is key to the implementation of Helius technology.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Neuro&v=1772566146613 "Schedule of future (projected) sales of companies in the market segment - Neuro")
Future (projected) sales of the market as a whole
Helius Medical develops and markets the PoNS device for the treatment of neurological symptoms caused by trauma. Demand depends on technology acceptance and patient affordability. This graph of general economic expectations reflects the financial health of consumers, influencing their ability to afford innovative, but often expensive, rehabilitation methods.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772566146674 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Helius Medical
Helius Medical Technologies develops and markets neurostimulation devices aimed at rehabilitating patients with neurological injuries. This chart shows the path to profitability in medical technology. The ability to generate revenue depends on regulatory approval and widespread adoption of its technology in clinical practice.
Market segment marginality - Neuro
Helius Medical Technologies is a neurotechnology company developing products for patients with neurological symptoms caused by disease or injury. This chart shows the average profitability in the neurology medical equipment sector. It helps assess the potential commercial success of its PoNS platform for patient rehabilitation.
Market marginality as a whole
Helius Medical Technologies develops and markets neurostimulation devices for the treatment of neurological symptoms. Like other companies in the medtech sector, its success depends on clinical data and market acceptance. This overall profitability chart does not reflect the company's specific growth drivers related to medical innovation.
Employees in the company, segment and market as a whole
Number of employees in the company Helius Medical
Helius Medical Technologies develops and markets neurostimulation devices. Its team comprises engineers, clinicians, and sales specialists. Growth in this chart may signal commercial expansion following regulatory approvals and entry into new markets.
Share of the company's employees Helius Medical within the market segment - Neuro
Helius Medical Technologies develops and commercializes technologies to improve neurological health. This chart illustrates its innovative approach to neurorehabilitation. It highlights the number of neuroscientists, medical engineers, and physical therapists working on a unique device for language stimulation to treat neurological symptoms that Helius brings together.
Number of employees in the market segment - Neuro
Helius Medical Technologies develops and commercializes technologies for neurological rehabilitation. This chart illustrates employment in neuroscience. The growing number of specialists in this field reflects the search for new methods to restore brain function after injuries and strokes, creating a market for innovative therapeutic devices like Helius's.
Number of employees in the market as a whole
Helius Medical Technologies, Inc. is a neurotechnology company developing therapies for patients with neurological diseases. Medical innovation requires highly qualified specialists. This chart illustrates the overall dynamics of the labor market, where the medical technology sector is playing an increasingly prominent role in creating the jobs of the future.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Helius Medical (HSDT)
Helius Medical, a neurotechnology company, possesses valuable intellectual capital. This chart shows how the market values its unique rehabilitation developments. The high cost per employee is a premium on innovation and the technology's potential to transform the lives of patients with neurological disorders.
%20of%20the%20company%20Helius%20Medical%20(HSDT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Helius-Medical-HSDT&v=1772566147088 "Chart of market capitalization per employee (in thousands of dollars) of the company Helius Medical (HSDT)")
Market capitalization per employee (in thousands of dollars) in the market segment - Neuro
Helius Medical has developed a device for the rehabilitation of patients with neurological injuries. The market capitalization per employee at this medical technology company reflects the market valuation of its unique PoNS technology. A comparison with the sector helps understand the potential investors see for this innovative treatment method.
%20by%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Neuro&v=1772566147146 "Market capitalization per employee (in thousands of dollars) by market segment - Neuro")
Market capitalization per employee (in thousands of dollars) for the overall market
Helius Medical Technologies is a neurotechnology company developing devices to treat neurological symptoms caused by injury or disease. This chart shows how the market evaluates the potential of a team of engineers and scientists to create and commercialize an innovative medical device capable of improving patients' quality of life.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772566147199 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Helius Medical (HSDT)
Helius Medical is a neurotechnology company commercializing its PoNS device for the treatment of neurological symptoms (such as multiple sclerosis). This chart, in negative territory, shows how much the company is investing in each employee (R&D, sales) to bring its innovative, yet niche, technology to market.
%20Chart%20Helius%20Medical%20(HSDT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Helius-Medical-HSDT&v=1772566147315 "Company Profit Per Employee (in thousands of dollars) Chart Helius Medical (HSDT)")
Profit per employee (in thousands of dollars) in the market segment - Neuro
Helius Medical Technologies develops and markets non-invasive neurostimulation devices aimed at improving the lives of people with neurological diseases. This chart reflects the commercial potential of their technology. It shows how effectively the company is able to monetize its innovative medical devices, which is an indicator of their clinical and market value.
%20in%20the%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Neuro&v=1772566147397 "Chart of profit per employee (in thousands of dollars) in the market segment - Neuro")
Profit per employee (in thousands of dollars) for the market as a whole
Helius Medical Technologies develops and markets neurostimulation (PoNS) devices for the treatment of neurological symptoms (such as multiple sclerosis). This chart shows how effectively the company is commercializing its unique technology. It reflects the balance between R&D, manufacturing, and marketing expenses compared to sales revenue.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772566147492 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Helius Medical (HSDT)
Helius Medical Technologies is in the commercialization phase of its device for rehabilitation after traumatic brain injuries. This graph shows how successfully the product is gaining market share. Increasing revenue per employee will indicate acceptance of the technology and an increase in the number of patients using it for rehabilitation.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Helius-Medical-HSDT&v=1772566147585 "Sales chart per company employee Helius Medical (HSDT)")
Sales per employee in the market segment - Neuro
Helius Medical (HSDT) is a neurotechnology company that developed the PoNS (Portable Neuromodulation Stimulator) device for treating the symptoms of multiple sclerosis and traumatic brain injury. This chart shows the average revenue per employee in the segment. Comparing HSDT to this benchmark demonstrates how effectively the company is commercializing its innovative neurostimulation technology.
Sales per employee for the market as a whole
Helius Medical (HSDT) is a neurotechnology company commercializing the PoNS device for the treatment of multiple sclerosis. The company is in the early sales stage. This metric demonstrates how successfully their small sales team is promoting this innovative and expensive technology to clinics. Its growth is an indicator of market acceptance.
Short shares by company, segment and market as a whole
Shares shorted by company Helius Medical (HSDT)
Helius Medical is developing a non-invasive device (PoNS) that stimulates the tongue to treat neurological symptoms (such as multiple sclerosis). This chart shows high market skepticism. Bears are betting that this technology lacks sufficient evidence and that the company will be unable to convince doctors and insurance companies of its effectiveness.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Helius-Medical-HSDT&v=1772566147991 "Short Shares Chart for the Company Helius Medical (HSDT)")
Shares shorted by market segment - Neuro
Helius Medical (HSDT) sells the PoNS device, a tongue stimulator designed to rehabilitate patients with neurological injuries. This chart highlights the pessimism in the sector. The surge in short positions across the industry is a bet that Helius will fail to commercialize its product. Investors doubt insurance companies will cover this expensive and niche therapy, making it commercially unviable.
Shares shorted by the overall market
Helius Medical is developing a wearable nerve stimulation device (PoNS) to aid in rehabilitation after brain injuries. This chart measures overall fear. When investors are pessimistic, they are skeptical of medical technology devices with a long path to market. They doubt the speed of PoNS adoption by doctors and patients and prefer not to risk selling HSDT shares.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Helius Medical (HSDT)
Helius Medical (HSDT) develops non-invasive brain stimulation technologies aimed at rehabilitating patients with traumatic brain injuries. It is a cutting-edge medical technology company. This chart measures price momentum. It helps identify when the stock is entering overbought territory (above 70) on FDA news or oversold territory (below 30) with no progress.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Helius-Medical-HSDT&v=1772566148135 "RSI 14 indicator chart for the company's stock Helius Medical (HSDT)")
RSI 14 Market Segment - Neuro
Helius Medical (HSDT) has developed the PoNS device. It's a non-invasive stimulator that "tickles" the tongue, aiding in the rehabilitation of patients with neurological disorders (post-stroke, MS). This graph measures the pulse of the Neurology/Medical Equipment sector. It helps differentiate HSDT technology from the generally overhyped or oversold medtech sector.
RSI 14 for the overall market
Helius Medical (HSDT) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast HSDT (Helius Medical)
Helius Medical is a neurotechnology company that developed the PoNS (Portable Neuromodulation Stimulator). It stimulates the tongue to aid in the rehabilitation of patients with neurological injuries (TBI, stroke). This chart shows the average price target from analysts based on their belief in the commercialization of this technology.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-HSDT-Helius-Medical&v=1772566148218 "A chart showing analyst consensus forecasts for the expected stock price. HSDT (Helius Medical)")
The difference between the consensus estimate and the actual stock price HSDT (Helius Medical)
Helius Medical is a medical technology company that developed PoNS, a unique device that stimulates the tongue to aid in the rehabilitation of patients with multiple sclerosis (MS). This chart shows how the current stock price differs from the "fair" value predicted by analysts. It reflects their belief in the commercialization of this technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-HSDT-Helius-Medical&v=1772566148252 "A chart showing the difference between the consensus forecast and the actual stock price. HSDT (Helius Medical)")
Analyst consensus forecast for stock prices by market segment - Neuro
Helius Medical is a medical company that developed PoNS, a non-invasive device that stimulates the tongue to aid in the rehabilitation of patients with neurological disorders (multiple sclerosis, stroke). This chart shows the overall expectations for the neuroscience sector, reflecting experts' confidence in this innovative R&D platform.
Analysts' consensus forecast for the overall market share price
Helius Medical (HSDT) is a medical company that has developed a device (PoNS) that stimulates language to aid in the rehabilitation of patients with neurological injuries (e.g., TBI). This chart shows the overall "risk appetite" in the market. For Helius, a company with an innovative but difficult-to-commercialize technology, overall optimism is important for funding and convincing insurance companies.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Helius Medical
Helius is a MedTech company with one bet: PoNS. It's a non-invasive device that stimulates the cranial nerve and is used (along with PHYSIO) to help patients recover from traumatic brain injury (TBI) or multiple sclerosis. This chart summarizes their adoption history, reflecting their (very slow) path to commercialization and their struggle to secure insurance reimbursement.
AKIMA Market Segment Index - Neuro
Helius Medical (HSDT) is a neurotechnology company that developed the PoNS device. It is a non-invasive language stimulator used in conjunction with rehabilitation therapy for patients with traumatic brain injuries and multiple sclerosis. The chart shows the average index for the segment, helping investors assess how this innovative technology compares to the market average.
The AKIM Index for the overall market
Helius Medical is a neurotechnology company that developed the PoNS device for neuromodulation (language stimulation) in rehabilitation. This chart, which reflects the market average, provides background information. It helps assess how this unique brain restoration technology compares to overall macroeconomic trends and insurance coverage.
